Federation Des Caisses Desjardins Du Quebec Ocugen, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $23.7 Billion
- Q3 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Ocugen, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 5,000 shares of OCGN stock, worth $5,950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,000
Previous 5,310
5.84%
Holding current value
$5,950
Previous $5,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding OCGN
# of Institutions
106Shares Held
60.4MCall Options Held
531KPut Options Held
433K-
Black Rock Inc. New York, NY17.9MShares$21.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$18.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.16MShares$4.95 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.94 Million0.31% of portfolio
-
Geode Capital Management, LLC Boston, MA3.68MShares$4.38 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $258M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...